SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000019617-24-000155
Filing Date
2024-01-25
Accepted
2024-01-25 11:11:16
Documents
1
Confirming Copy
 

Document Format Files

Seq Description Document Type Size
1 FILING REGENXBIO INC. REGENXBIO_Inc.htm SC 13G/A 88010
  Complete submission text file 0000019617-24-000155.txt   90067
Mailing Address 383 MADISON AVENUE NEW YORK NY 10017
Business Address 383 MADISON AVENUE NEW YORK NY 10017 2122706000
JPMORGAN CHASE & CO (Filed by) CIK: 0000019617 (see all company filings)

IRS No.: 132624428 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6021 National Commercial Banks
(CF Office: 02 Finance)

Mailing Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9804 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Subject) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89108
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)